Astonishing results – the application of Pregnacare preparation (Vitabiotics, UK) allows decreasing the level of increased bleeding sickness (hemorrhagic syndrome) of newborn more than twice! The statistical data state that this syndrome is the most frequent cause of increased level of death rate at the earliest stages of life of premature newborn! In order to allow thorough investigation of this phenomenon by prominent Ukrainian specialists and to introduce new methodology of preventing this pathology, Delta Medical gave a hemocoagulometer (a device, determining the indicators of blood coagulation) to Odessa Regional Perinatal Centre.
To define the efficiency of the preparation it was necessary to investigate the indicators of blood coagulation of newborn according to the fact of pregnant women taking complex vitamin and mineral preparation, containing vitamin K. The selected group included 86 pregnant women and 96 newborn. At present the only complex preparation with vitamin K in its composition, registered in Ukraine and allowed for pregnant women, is Pregnacare. The producer of this multivitamin complex – Vitabiotics company – was established in London in 1971 and has been the leading English producer of health care preparations for more than 35 years. Vitabiotics is one of the most dynamic and developing companies among the producers of medical preparations in England (annual increase is 25-30%). It is also among the dozen of companies which are leaders in health care. In 2001 the company was included into the top-list of 100 most prominent innovational companies in the market (BT Vision 100 Award). In 2003 it received Queen’s Award for International Trade. While developing preparations, Vitabiotics is cooperating with prominent scientific and research centres of the United Kingdom. Quality and efficiency of preparations have been proven by numerous clinical researches in many countries of the world and confirmed both by British and international competent scientific, medical, and professional associations, organizations, and funds. The conclusions of experts concerning the study on efficiency of Pregnacare exceeded all the expectations: the level of frequency of hemorrhagic syndrome of newborn was decreased two-fold.
Information about research performed was published in specialized press and became the basis of the report of Professor Nagornaya V.F., who was one of organizers of this programme, at the International congress Urgent Issues of Obstetrics, Gynecology, and Perinatology which took place in Sudak in May 2008.
Being the official representative of Vitabiotics, Delta Medical is addressing the urgent social problem again and taking active measures to solve it.
Information:
Delta Medical company was founded in 1999.
There are more than 600 employees in the company all over Ukraine and more than 100 in other CIS countries.
The partners of Delta Medical include more than 30 world pharmaceutical companies, including: Bristol-Myers Squibb (USA), Convatec (USA), Medinova (Switzerland), Mentholatum (Great Britain), Molteni (Italy), Laboratories UPSA (France), Laboratories URGO (France), Forest Labs (USA/Ireland), Vitabiotics (Great Britain), Sebapharma (Germany), Schonen (Switzerland), BioGaia (Sweden), Respironics (USA), Laderma (Australia), Stiefel (USA), Arkopharma (France), Biosyn (Germany), Nepentes (Poland), Gilead (USA), Neomedic (Great Britain), CSC/Angelini Francesco (Italy), Nutricia (Netherlands), Thornton+Ross (Great Britain), Spirig (Switzerland), Sally Hansen (USA), Lil Drug Store (USA).
Today there are more than 300 items of products in Delta Medical companys portfolio, and they include not only medical preparations and goods of medicinal destination, but also medical cosmetics, dietary supplements, nutrition products.
43, Chornovola street, Vyshneve, Ukraine, 08132
tel. + 38 044 593-33-55 fax + 38 044 593-33-54 www.deltamedical.com.ua